Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: Reproducibility of grade and advantages of proliferation index

John S. Meyer, Consuelo Alvarez, Clara Milikowski, Neal Olson, Irma Russo, Jose Russo, Andrew Glass, Barbara A. Zehnbauer, Karen Lister, Reza Parwaresch

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Questions of reproducibility and efficacy of histologic malignancy grading relative to alternative proliferation index measurements for outcome prediction remain unanswered. Microsections of specimens from the Cooperative Breast Cancer Tissue Resource (CBCTR) were evaluated by seven pathologists for reproducibility of grade and classification. Nuclear figure classification was assessed using photographs. Grade was assigned by the Bloom-Richardson method, Nottingham modification. Proliferation index was evaluated prospectively by deoxyribose nucleic acid precursor uptake with thymidine (autoradiographic) or bromodeoxyuridine (immunohistochemical) labeling index using fresh tissue from 631 node-negative breast cancer patients accessioned at St Luke's Hospital. A modified Nottingham-Bloom-Richardson grade was derived from histopathologic data. Median post-treatment observation was 6.4 years. Agreement on classification of nuclear figures (N = 43) was less than good by kappa statistic (κ = 0.38). Grade was moderately reproducible in four trials (N = 10,10,19, 10) with CBCTR specimens (κ = 0.50-0.59). Of components of Bloom-Richardson grade, agreement was least for nuclear pleomorphism (κ = 0.37-0.50), best for tubularity (K = 0.57-0.83), and intermediate for mitotic count (K = 0.45-0.64). Bloom-Richardson grade was a univariate predictor of prognosis in node-negative St Luke's patients, and was improved when mitotic count was replaced by labeling index (low, mid, or high). When labeling index was added to a multivariate model containing tumor size and vessel invasion, grade was no longer a significant predictor of tumor-specific relapse-free or overall survival. Mitotic index predicted best when intervals were lowered to 0-2, 3-10, and > 10 mitotic figures per ten 0.18 mm2 high-power fields. We conclude that Nottingham-Bloom-Richardson grades remain only modestly reproducible. Prognostically useful components of grade are mitotic index and tubularity. The Nottingham-Bloom-Richardson system can be improved by lowering cutoffs for mitotic index and by counting 20-30 rather than 10 high-power fields. Measurement of proliferation index by immunohistochemically detectable markers will probably give superior prognostic results in comparison to grade.

Original languageEnglish
Pages (from-to)1067-1078
Number of pages12
JournalModern Pathology
Volume18
Issue number8
DOIs
StatePublished - Aug 1 2005

Fingerprint

Mitotic Index
Breast Neoplasms
Nucleic Acid Precursors
Deoxyribose
Neoplasms
Bromodeoxyuridine
Thymidine
Observation
Recurrence
Survival
Therapeutics

Keywords

  • Bloom-richardson
  • Breast neoplasms
  • Bromodeoxyuridine
  • Cell kinetics
  • Grade
  • Proliferation
  • Reproducibility

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index : Reproducibility of grade and advantages of proliferation index. / Meyer, John S.; Alvarez, Consuelo; Milikowski, Clara; Olson, Neal; Russo, Irma; Russo, Jose; Glass, Andrew; Zehnbauer, Barbara A.; Lister, Karen; Parwaresch, Reza.

In: Modern Pathology, Vol. 18, No. 8, 01.08.2005, p. 1067-1078.

Research output: Contribution to journalArticle

Meyer, John S. ; Alvarez, Consuelo ; Milikowski, Clara ; Olson, Neal ; Russo, Irma ; Russo, Jose ; Glass, Andrew ; Zehnbauer, Barbara A. ; Lister, Karen ; Parwaresch, Reza. / Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index : Reproducibility of grade and advantages of proliferation index. In: Modern Pathology. 2005 ; Vol. 18, No. 8. pp. 1067-1078.
@article{609b4f6677a342c7a0fb89f976fcc0e3,
title = "Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: Reproducibility of grade and advantages of proliferation index",
abstract = "Questions of reproducibility and efficacy of histologic malignancy grading relative to alternative proliferation index measurements for outcome prediction remain unanswered. Microsections of specimens from the Cooperative Breast Cancer Tissue Resource (CBCTR) were evaluated by seven pathologists for reproducibility of grade and classification. Nuclear figure classification was assessed using photographs. Grade was assigned by the Bloom-Richardson method, Nottingham modification. Proliferation index was evaluated prospectively by deoxyribose nucleic acid precursor uptake with thymidine (autoradiographic) or bromodeoxyuridine (immunohistochemical) labeling index using fresh tissue from 631 node-negative breast cancer patients accessioned at St Luke's Hospital. A modified Nottingham-Bloom-Richardson grade was derived from histopathologic data. Median post-treatment observation was 6.4 years. Agreement on classification of nuclear figures (N = 43) was less than good by kappa statistic (κ = 0.38). Grade was moderately reproducible in four trials (N = 10,10,19, 10) with CBCTR specimens (κ = 0.50-0.59). Of components of Bloom-Richardson grade, agreement was least for nuclear pleomorphism (κ = 0.37-0.50), best for tubularity (K = 0.57-0.83), and intermediate for mitotic count (K = 0.45-0.64). Bloom-Richardson grade was a univariate predictor of prognosis in node-negative St Luke's patients, and was improved when mitotic count was replaced by labeling index (low, mid, or high). When labeling index was added to a multivariate model containing tumor size and vessel invasion, grade was no longer a significant predictor of tumor-specific relapse-free or overall survival. Mitotic index predicted best when intervals were lowered to 0-2, 3-10, and > 10 mitotic figures per ten 0.18 mm2 high-power fields. We conclude that Nottingham-Bloom-Richardson grades remain only modestly reproducible. Prognostically useful components of grade are mitotic index and tubularity. The Nottingham-Bloom-Richardson system can be improved by lowering cutoffs for mitotic index and by counting 20-30 rather than 10 high-power fields. Measurement of proliferation index by immunohistochemically detectable markers will probably give superior prognostic results in comparison to grade.",
keywords = "Bloom-richardson, Breast neoplasms, Bromodeoxyuridine, Cell kinetics, Grade, Proliferation, Reproducibility",
author = "Meyer, {John S.} and Consuelo Alvarez and Clara Milikowski and Neal Olson and Irma Russo and Jose Russo and Andrew Glass and Zehnbauer, {Barbara A.} and Karen Lister and Reza Parwaresch",
year = "2005",
month = "8",
day = "1",
doi = "10.1038/modpathol.3800388",
language = "English",
volume = "18",
pages = "1067--1078",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index

T2 - Reproducibility of grade and advantages of proliferation index

AU - Meyer, John S.

AU - Alvarez, Consuelo

AU - Milikowski, Clara

AU - Olson, Neal

AU - Russo, Irma

AU - Russo, Jose

AU - Glass, Andrew

AU - Zehnbauer, Barbara A.

AU - Lister, Karen

AU - Parwaresch, Reza

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Questions of reproducibility and efficacy of histologic malignancy grading relative to alternative proliferation index measurements for outcome prediction remain unanswered. Microsections of specimens from the Cooperative Breast Cancer Tissue Resource (CBCTR) were evaluated by seven pathologists for reproducibility of grade and classification. Nuclear figure classification was assessed using photographs. Grade was assigned by the Bloom-Richardson method, Nottingham modification. Proliferation index was evaluated prospectively by deoxyribose nucleic acid precursor uptake with thymidine (autoradiographic) or bromodeoxyuridine (immunohistochemical) labeling index using fresh tissue from 631 node-negative breast cancer patients accessioned at St Luke's Hospital. A modified Nottingham-Bloom-Richardson grade was derived from histopathologic data. Median post-treatment observation was 6.4 years. Agreement on classification of nuclear figures (N = 43) was less than good by kappa statistic (κ = 0.38). Grade was moderately reproducible in four trials (N = 10,10,19, 10) with CBCTR specimens (κ = 0.50-0.59). Of components of Bloom-Richardson grade, agreement was least for nuclear pleomorphism (κ = 0.37-0.50), best for tubularity (K = 0.57-0.83), and intermediate for mitotic count (K = 0.45-0.64). Bloom-Richardson grade was a univariate predictor of prognosis in node-negative St Luke's patients, and was improved when mitotic count was replaced by labeling index (low, mid, or high). When labeling index was added to a multivariate model containing tumor size and vessel invasion, grade was no longer a significant predictor of tumor-specific relapse-free or overall survival. Mitotic index predicted best when intervals were lowered to 0-2, 3-10, and > 10 mitotic figures per ten 0.18 mm2 high-power fields. We conclude that Nottingham-Bloom-Richardson grades remain only modestly reproducible. Prognostically useful components of grade are mitotic index and tubularity. The Nottingham-Bloom-Richardson system can be improved by lowering cutoffs for mitotic index and by counting 20-30 rather than 10 high-power fields. Measurement of proliferation index by immunohistochemically detectable markers will probably give superior prognostic results in comparison to grade.

AB - Questions of reproducibility and efficacy of histologic malignancy grading relative to alternative proliferation index measurements for outcome prediction remain unanswered. Microsections of specimens from the Cooperative Breast Cancer Tissue Resource (CBCTR) were evaluated by seven pathologists for reproducibility of grade and classification. Nuclear figure classification was assessed using photographs. Grade was assigned by the Bloom-Richardson method, Nottingham modification. Proliferation index was evaluated prospectively by deoxyribose nucleic acid precursor uptake with thymidine (autoradiographic) or bromodeoxyuridine (immunohistochemical) labeling index using fresh tissue from 631 node-negative breast cancer patients accessioned at St Luke's Hospital. A modified Nottingham-Bloom-Richardson grade was derived from histopathologic data. Median post-treatment observation was 6.4 years. Agreement on classification of nuclear figures (N = 43) was less than good by kappa statistic (κ = 0.38). Grade was moderately reproducible in four trials (N = 10,10,19, 10) with CBCTR specimens (κ = 0.50-0.59). Of components of Bloom-Richardson grade, agreement was least for nuclear pleomorphism (κ = 0.37-0.50), best for tubularity (K = 0.57-0.83), and intermediate for mitotic count (K = 0.45-0.64). Bloom-Richardson grade was a univariate predictor of prognosis in node-negative St Luke's patients, and was improved when mitotic count was replaced by labeling index (low, mid, or high). When labeling index was added to a multivariate model containing tumor size and vessel invasion, grade was no longer a significant predictor of tumor-specific relapse-free or overall survival. Mitotic index predicted best when intervals were lowered to 0-2, 3-10, and > 10 mitotic figures per ten 0.18 mm2 high-power fields. We conclude that Nottingham-Bloom-Richardson grades remain only modestly reproducible. Prognostically useful components of grade are mitotic index and tubularity. The Nottingham-Bloom-Richardson system can be improved by lowering cutoffs for mitotic index and by counting 20-30 rather than 10 high-power fields. Measurement of proliferation index by immunohistochemically detectable markers will probably give superior prognostic results in comparison to grade.

KW - Bloom-richardson

KW - Breast neoplasms

KW - Bromodeoxyuridine

KW - Cell kinetics

KW - Grade

KW - Proliferation

KW - Reproducibility

UR - http://www.scopus.com/inward/record.url?scp=24044552649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044552649&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800388

DO - 10.1038/modpathol.3800388

M3 - Article

C2 - 15920556

AN - SCOPUS:24044552649

VL - 18

SP - 1067

EP - 1078

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 8

ER -